Pharma
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Angiotech pharmaceuticals announces fda 510 clearance of the option inferior vena cava filter
Angiotech Pharmaceuticals, 06/09/09

Angiotech Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has granted 510 clearance for the Option Inferior Vena Cava Filter in the United States, for use in both permanent and retrievable indications. Angiotech holds exclusive worldwide rights to market and distribute the Option IVC Filter, which it obtained in a license agreement with privately held Rex Medical, LP, as previously announced in March 2008.

Today in M&A/Partnerships...keeping you current

Covidien Announces Definitive Agreement to Sell U.S. Radiopharmacies
Covidien, 12/18/09

MediciNova and Avigen Stockholders Approve Merger
Avigen, 12/18/09

GlaxoSmithKline and NanoBio announce OTC licensing agreement for cold sore treatment
GlaxoSmithKline, 12/18/09

 See all of M&A/Partnerships

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address